Clinical Interpretation of Platelet Activation Marker sCLEC ‐2 in Antiphospholipid Syndrome

Key Points

• The study aims to interpret the clinical significance of the platelet activation marker sCLEC-2 in antiphospholipid syndrome.
• Comparison of sCLEC-2 and sCLEC-2/D-dimer ratios in APS and non-APS groups.
• Observational analysis of the differences between the groups.
• Recommendation for prospective studies to assess dynamic changes.
• Raised levels of sCLEC-2 were observed in both APS and non-APS groups.
• Modest differences in sCLEC-2/D-dimer ratios were noted between the groups.
• Clinical implications of these findings suggest the need for further investigation.